RxDoctor Payments Data

Eric Kanter, MD

Retina Specialist · Livingston, NJNPI 1558365411

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 37 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $304 and has fallen 83.4% since, to $51 in 2025. That places this record below the midpoint for retina specialist clinicians in NJ, where the typical reported total is $2,776.

$725in general payments, 2019–2025

Across 37 payments — averaging $19.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$135
  • AbbVie$110
  • Genentech USA, Inc.$101
  • Regeneron Healthcare Solutions, Inc.$84
  • Astellas Pharma US Inc$77
  • Novartis$59
  • plus $160 from 4 others

What the payments were for

  • Food & beverage$725100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Alcon1$135
AbbVie(2 entities)7$110
Genentech USA, Inc.6$101
Regeneron Healthcare Solutions, Inc.6$84
Astellas Pharma US Inc5$77
Novartis4$59
Apellis Pharmaceuticals, Inc.2$46
Biogen2$45
Alimera Sciences, Inc.3$40
US Oncology Corporate, Inc.1$29

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$725 in reported general payments places this provider in the 15th percentile of 35 retina specialist providers in New Jersey.

See all retina specialist providers in New Jersey

Medicare billing

Part B allowed, 2024
$1,840,060
Medicare patients
684
Services billed
17,537

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LumiganBimatoprost15$5,100
Prednisolone Acetate54$1,722
Tobramycin-DexamethasoneTobramycin/Dexamethasone28$1,351
Brimonidine Tartrate11$608
Ketorolac Tromethamine26$476
Latanoprost26$224

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLumigan$110$5,10015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 15th percentile of 35 retina specialist providers in New Jersey.

Other retina specialist in Livingston

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →